We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
The effect on plasma glucose and serum insulin of varying amounts of insulin added to the dialysis fluid was studied in a total of 10 diabetic patients on chronic peritoneal dialysis (PD). The studies were carried out in a 3-day and a 14-day model, using dialysis fluid with two different concentrations of glucose (75 mmol/l (isotonic and 200 mmol/l (hypertonic)) and with addition of either 0, 6, 12 or 24 U/l of immunoreactive insulin (IRI) to the dialysis fluid. Plasma glucose and serum insulin were determined before, during and after dialysis. Dialysate concentrations of glucose and insulin were determined for each cycle. Addition of 12 and 24 U of IRI/I resulted in a significant rise in serum insulin. With the isotonic dialysis fluid no insulin was required to control plasma glucose during PD. With the hypertonic dialysis fluid addition of 12 U of IRI/I was optimal for the control of plasma glucose, while 24 U/I produced post-dialytic hypoglucemia.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app